Novoprotein Scientific Inc. (SHA:688137)
China flag China · Delayed Price · Currency is CNY
113.77
-3.83 (-3.26%)
At close: Nov 17, 2026

Novoprotein Scientific Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
158.95146.07127.4153.05264.33341.79
Other Revenue
0.370.370.150.140.220.11
159.32146.44127.56153.19264.55341.9
Revenue Growth
8.14%14.80%-16.73%-42.09%-22.62%90.11%
Cost of Revenue
73.4775.1973.4770.6954.354.55
Gross Profit
85.8571.2554.0882.5210.25287.35
Selling, General & Admin
100.11100.05101.0987.8482.9469.29
Research & Development
79.5164.0649.9244.7941.134.1
Other Operating Expenses
1.381.291.290.673.013.9
Operating Expenses
180.3163.51154.39131.72128.27111.17
Operating Income
-94.45-92.25-100.31-49.2281.98176.17
Interest Expense
-2.29-2.54-3.59-3.59-4.05-1.8
Interest & Investment Income
26.623241.4849.429.072.39
Currency Exchange Gain (Loss)
-1.35-1.350.710.652.84-0.81
Other Non Operating Income (Expenses)
-2.52-0.88-0.43-0.49-0.16-0.18
EBT Excluding Unusual Items
-73.98-65.03-62.14-3.2389.69175.77
Gain (Loss) on Sale of Investments
---1.8-1.753.55-0.14
Gain (Loss) on Sale of Assets
-0.010.720.05-0.09-0.040.03
Asset Writedown
-3.2-5.98-6.61---0.15
Other Unusual Items
-0.09-0.0916.2911.2912.980.72
Pretax Income
-77.29-70.37-54.226.22106.18176.23
Income Tax Expense
19.547.410.2-6.6215.4627.22
Net Income
-96.83-77.78-54.4212.8490.72149.01
Net Income to Common
-96.83-77.78-54.4212.8490.72149.01
Net Income Growth
----85.84%-39.12%79.42%
Shares Outstanding (Basic)
697070715740
Shares Outstanding (Diluted)
697070715740
Shares Change
-0.77%0.45%-2.23%25.05%42.83%151.52%
EPS (Basic)
-1.40-1.11-0.780.181.593.73
EPS (Diluted)
-1.40-1.11-0.780.181.593.73
EPS Growth
----88.68%-57.37%-28.67%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-195.06-92.25-31.5724.22-33.391.02
Free Cash Flow Per Share
-2.81-1.32-0.450.34-0.580.03
Dividend Per Share
---0.5000.500-
Dividend Growth
---0%--
Gross Margin
53.89%48.66%42.40%53.85%79.47%84.05%
Operating Margin
-59.28%-63.00%-78.64%-32.13%30.99%51.53%
Profit Margin
-60.77%-53.12%-42.66%8.38%34.29%43.58%
Free Cash Flow Margin
-122.43%-62.99%-24.75%15.81%-12.62%0.30%
EBITDA
-80.59-79.25-88.44-39.1190.5180.01
EBITDA Margin
-50.58%-54.12%-69.33%-25.53%34.21%52.65%
D&A For EBITDA
13.8613.0111.8710.118.523.83
EBIT
-94.45-92.25-100.31-49.2281.98176.17
EBIT Margin
-59.28%-63.00%-78.64%-32.13%30.99%51.53%
Effective Tax Rate
----14.56%15.45%
Revenue as Reported
159.32146.44127.56153.19264.55341.9